325 related articles for article (PubMed ID: 9951596)
21. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
Chang J; Denham L; Dong EK; Malek K; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
[TBL] [Abstract][Full Text] [Related]
22. Fine-needle aspiration cytology of spindle cell lesions of the breast.
Chhieng DC; Cangiarella JF; Waisman J; Fernandez G; Cohen JM
Cancer; 1999 Dec; 87(6):359-71. PubMed ID: 10603190
[TBL] [Abstract][Full Text] [Related]
23. Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma.
Komenaka IK; El-Tamer M; Pile-Spellman E; Hibshoosh H
Arch Surg; 2003 Sep; 138(9):987-90. PubMed ID: 12963656
[TBL] [Abstract][Full Text] [Related]
24. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
25. Recurrent giant fibroadenomas with transformation to cystosarcoma phyllodes in a 17-year-old girl: a rare case report from Syria.
Ismail S; Alaidi S; Jouni S; Kassab Y; Al-Shehabi Z
J Med Case Rep; 2019 Dec; 13(1):378. PubMed ID: 31862014
[TBL] [Abstract][Full Text] [Related]
26. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
Lee A; James J; Whisker L; Rakha EA; Ellis IO
Ann R Coll Surg Engl; 2022 May; 104(5):361-366. PubMed ID: 34939848
[TBL] [Abstract][Full Text] [Related]
27. Paediatric fibroepithelial lesions revisited: pathological insights.
Tay TK; Chang KT; Thike AA; Tan PH
J Clin Pathol; 2015 Aug; 68(8):633-41. PubMed ID: 25998513
[TBL] [Abstract][Full Text] [Related]
28. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast.
Resetkova E; Khazai L; Albarracin CT; Arribas E
Breast J; 2010; 16(6):573-80. PubMed ID: 21070433
[TBL] [Abstract][Full Text] [Related]
29. Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
Al-Arnawoot B; Scaranelo A; Fleming R; Kulkarni S; Menezes RJ; McCready D; Done S; Freitas V
J Surg Oncol; 2020 Sep; 122(3):382-387. PubMed ID: 32396665
[TBL] [Abstract][Full Text] [Related]
30. Determining whether excision of all fibroepithelial lesions of the breast is needed to exclude phyllodes tumor: upgrade rate of fibroepithelial lesions of the breast to phyllodes tumor.
Van Osdol AD; Landercasper J; Andersen JJ; Ellis RL; Gensch EM; Johnson JM; De Maiffe B; Marcou KA; Al-Hamadani M; Vang CA
JAMA Surg; 2014 Oct; 149(10):1081-5. PubMed ID: 25162470
[TBL] [Abstract][Full Text] [Related]
31. Fibroadenoma With Pleomorphic Stromal Giant Cells: It's Not as Bad as It Looks!
Wawire J; Singh K; Steinhoff MM
Int J Surg Pathol; 2017 Aug; 25(5):425-427. PubMed ID: 28413897
[TBL] [Abstract][Full Text] [Related]
32. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
33. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy.
Wiratkapun C; Piyapan P; Lertsithichai P; Larbcharoensub N
Diagn Interv Radiol; 2014; 20(1):27-33. PubMed ID: 24356293
[TBL] [Abstract][Full Text] [Related]
34. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm.
Gould DJ; Salmans JA; Lassinger BK; Contreras A; Gutierrez C; Bonefas E; Liscum KR; Silberfein EJ
J Surg Res; 2012 Nov; 178(1):299-303. PubMed ID: 22524977
[TBL] [Abstract][Full Text] [Related]
36. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
Seow DYB; Tay TKY; Tan PH
Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
Aiyer HM; Jain M; Thomas S; Logani KB
Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
[TBL] [Abstract][Full Text] [Related]
38. Fibroepithelial lesions of the breast: a comprehensive morphological and outcome analysis of a large series.
Slodkowska E; Nofech-Mozes S; Xu B; Parra-Herran C; Lu FI; Raphael S; Zubovits J; Hanna W
Mod Pathol; 2018 Jul; 31(7):1073-1084. PubMed ID: 29449684
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
40. Cytologic evaluation of phyllodes tumors as compared to fibroadenomas of the breast.
Shimizu K; Masawa N; Yamada T; Okamoto K; Kanda K
Acta Cytol; 1994; 38(6):891-7. PubMed ID: 7992575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
